Background {#Sec1}
==========

Severe acute pancreatitis (SAP) is a devastating disease that is characterized by a high mortality rate (ranging from 15% to as high as 85%) due to the development of pancreatic and extra-pancreatic necrosis infection, and multi-system organ failure (MOF) \[[@CR1], [@CR2]\]. The management of SAP is complicated because of the incomplete understanding of the pathogenesis and multi-causation of the disease, uncertainties in predicting outcome and limited effective treatment modalities \[[@CR2], [@CR3]\]. Gastrointestinal fistula (GIF) is a well-recognized complication secondary to SAP, although the incidence of GIF in SAP is low and sporadically reported in the literature. As previously reported, GIF is one of the most fatal and intractable complications after SAP, and associated with other major complications and serious clinical consequences, such as hemorrhage and exacerbation of infection which can lead to a fatal outcome \[[@CR4]--[@CR7]\]. The etiology and pathogenesis of GIF in patients with SAP involve complex processes, which are far from fully understood. Indeed, the management of GIF in SAP is complicated and controversial, which could lead to a prolonged hospital course, and significant morbidity and mortality \[[@CR8], [@CR9]\]. The sites of fistula may involve the stomach, duodenum, jejunum, ileum, and colon, either in localization or diffusion. GIF may result from direct erosion from digestive enzymes excreted by the inflamed pancreas on the adjacent gastrointestinal (GI) tract, or it could occur as a consequence of intestinal necrosis due to vascular thrombosis in an area of inflammation and infection. In addition, GIF may be associated with iatrogenic intervention \[[@CR10]--[@CR12]\].

It has been reported that GIF may cause none of additional symptoms in some cases, which are usually detected incidentally on radiologic imaging or during surgical intervention \[[@CR10], [@CR13]--[@CR15]\]. The resulting events of GIF we observed also confused us frequently, which led to either further complications or spontaneous resolution. Interestingly, more of GIF often tended to relatively facile resolution rather than thorny complications, especially serious GIF, such as the case of multiple or diffuse. Little data exists regarding the risk factors for this complication, and few publications provide precise and adequate predictions of the risk for GIF in patients with SAP. Therefore, the early prediction of GIF and specific targeted interventions are imperative to reduce GIF-related mortality \[[@CR16], [@CR17]\]. In this retrospective study we analyzed the data from patients with SAP to determine the risk factors for developing GIF. Moreover, we also studied the different clinical characteristics and outcomes of GIF in the setting of SAP.

Methods {#Sec2}
=======

Patient enrollment {#Sec3}
------------------

From January 2011 to January 2016, patients with a primary diagnosis of SAP admitted to Departments of Emergency, Hepatopancreatobiliary Surgery, Gastroenterology, Surgical Intensive Care Units of Zhongshan Hospital (Xiamen, China) within 72 h from the onset of the disease were screened for enrollment, and including some critical patients confirmed SAP who transferred from other facilities. Demographic and clinical characteristics of patients were collected at the time of admission.

Our criteria are consistent with that recommended in the Revised Atlanta Classification (RAC-2013) \[[@CR18]\] and the revised guidelines of the Italian Association for the Study of the Pancreas (AISP-2014) \[[@CR9]\]. To ensure the inclusion of only eligible patients with SAP, only those with an acute inflammatory process of the pancreas associated with variable severity were included, such as the presence of organ failure and local/systemic complications. Patients who met the following criteria were excluded: (1) patients developed GIF after iatrogenic intervention or surgical management;(2) younger than 18 years old age; (3) previous diagnosis of chronic liver and gastrointestinal disease; (4) pregnancy or severe immune system disorders; (5) end-stage chronic disease; (6) patients with incomplete data (e.g., deceased within 24 h after admission, missing computed tomography (CT) diagnosis, or termination of treatment on halfway); (7) patients with chronic pancreatitis, known malignancy were excluded.

Diagnosis and classification of SAP {#Sec4}
-----------------------------------

According to RAC-2013 and AISP-2014, the diagnosis of SAP requires clinical course, laboratory parameters and imaging evaluation such as contrast-enhanced CT (CECT), ultrasonography (US) and/or magnetic resonance imaging (MRI), Endoscopic ultrasound (EUS) \[[@CR19]--[@CR21]\]. The severity of SAP is stratified moderately severe (MSAP) and severe (SAP). MSAP is defined as the presence of transient organ failure (\<48 h), local complications or exacerbation of comorbid disease. SAP is defined as persistent organ failure (\> 48 h) affecting respiration, renal function or the cardiovascular system. The SAP diagnosis requires at least one of the following criteria: (a) Acute Physiology and Chronic Health Evaluation II (APACHE II) score 8; (b) Ranson score 3; (c) organ failure (i.e., transient and persistent); and (d) local complications (i.e., necrosis, abscess or pseudocyst) \[[@CR22]\]. The presence of organ failure was defined by Modified Marshall Scoring System \[[@CR18], [@CR23]\]. Local complications have been defined in RAC-2013, include acute pancreatic or peripancreatic fluid collection (APFC), acute necrotic collection (ANC), and walled-off necrosis (WON), pancreatic pseudocysts. IPN is defined as the presence of infection in the development of ANCs and WONs. Other local complications include pancreatic fistula, gastric outlet dysfunction, splenic and portal vein thrombosis, gastrointestinal necrosis and fistula, hemorrhage etc \[[@CR24]--[@CR26]\]. Systemic complications are involved as exacerbation of preexisting conditions like systemic inflammatory response syndrome (SIRS), coronary artery disease, congestive cardiac failure, chronic obstructive pulmonary disease, diabetes, and chronic liver disease, precipitated by acute pancreatitis \[[@CR27]\]. GIF is defined as pathological communications that connect any portion of GI tract with the necrotic cavity, the peritoneal space, the retroperitoneal areas, or another internal organ. For overlapped with clinical manifestations of pancreatitis, diagnosis of GIF is often based on fistulography, digestive endoscopy, or operative findings \[[@CR28]\].

Etiologies {#Sec5}
----------

The etiology was considered to be of biliary origin when biliary tract stones were detected by US, CT or magnetic resonance cholangiopancreatography (MRCP), endoscopic retrograde cholangiopancreatography (ERCP). Alcohol was considered to be secondly etiological factor. For pancreatitis due to hypertriglyceridemia (HTG), a serum triglyceride (TG) level of more than 1000 mg/dL or 500--1000 mg/dL with a history of HTG was necessary, in addition to exclusion of other triggers. Lacking any of the above evidence or other direct causes, any unexplained pancreatitis, such as sphincter of Oddi dysfunction, pregnancy associated, ampullary obstruction, hyper-calcemia, drugs related and autoimmune, were defined as idiopathic AP in this study \[[@CR29]\].

Clinical management protocol {#Sec6}
----------------------------

Immediately after admission, all patients administrated individualized conservative therapy for SAP that included intensive monitoring, fluid resuscitation, oxygen administration, fasting, analgesia and suppression of pancreatic exocrine function by pharmacological agents, such as somatostatin. Nasoduodenal feeding tubes were placed, and feeding was initiated 48^\_^120 h after admission. EEN was defined as feeding within 48^\_^72 h after admission. Additionally, antibiotic therapies were guided by the results of culture and sensitivity. Rather than preventing infection, antibiotics were prescribed in these often critical patients with established infected necrosis or the presence of other infections (e.g., biliary tract, urinary tract, pulmonary, etc.). CECT was performed routinely for all patients within 72 h after admission or earlier when warranted by diagnostic dilemmas. IPN was diagnosed according to the positive gram stain and culture results of pancreatic or peripancreatitic necrotic tissue obtained by means of CT guided fine needle aspiration, or from the first percutaneous drainage or operation. IPN, WON and pseudocyst with complications were managed with a minimally invasive based step-up approach firstly, next step was performed if there was no clinical improvement. Nonsurgical procedures included percutaneous drainage and continuous negative pressure irrigation. Once GIF in patients with SAP was confirmed, which in most cases were already at least 2 weeks after initiating EEN. Enteral nutrition (EN) was deprived conditionally, and intra or extra-luminal drainage (applicable for the localized GIF), or enterostomy (applicable for the diffuse GIF) might be performed if necessary by the rationale of minimally invasive procedure, as well as interventional management with a step-up approach for SAP.

Data collection {#Sec7}
---------------

Data pertaining to clinical characteristics, including laboratory parameters, imaging record, phase and location of GIF, intervention for GIF, and outcomes were recorded. The metrics analyzed in the present investigation included demographic characteristics like age, gender, cause of illness, and clinical parameters such as MCTSI, APACHE II score, C-reactive protein (CRP) level, intra-abdominal pressure (IAP), blood type and occurrence of IPN. All the laboratory results were obtained at the Central Laboratory of Zhongshan Hospital according to the standard protocols. IAP was measured with a catheter inserted into the bladder, and patients underwent EEN were also documented.

Statistical analysis {#Sec8}
--------------------

SPSS 22.0 software (IBM SPSS Statistics; IBM Corporation; Armonk, NY) was used for data analysis. The distributions of quantitative variables were tested. Normally and non-normally distributed quantitative variables were presented as the median (interquartile range), respectively. Continuous variables were compared between the groups using an unpaired *t*-test and a paired *t*-test within each group. Categorical variables were compared using the Chi-square test. For small samples, analysis of variance and Fisher's exact test were used to analyze continuous and categorical variables as appropriate. Statistical significance was set at *P* \< 0.05.

To identify risk factors for GIF, several series of univariate logistics regression analyses were performed involving 15 indices above mentioned. Variables that showed statistical significance were tested in further multiple logistic regression analyses with the stepwise method.

Results {#Sec9}
=======

During the observational period, 344 patients were enrolled in the analyses. The demographic data and clinical characteristics of both GIF and non-GIF groups are shown in Table [1](#Tab1){ref-type="table"}. Of the 344 patients, GIF developed in 52 patients (15.12%) and most of the GIF cases were confirmed clinically 4-8 weeks after onset of the disease. Table [2](#Tab2){ref-type="table"} shows the results of the univariate regression analysis of GIF in SAP. Hyperlipidemia, MCTSI, APACHE II score, EEN, B blood type and WON showed significant difference between patients with or without GIF. The results of our study correlate well with the statistical results shown in Table [1](#Tab1){ref-type="table"}, which also suggests differences in respect of these six parameters between GIF and non-GIF patients. Taking these significant variables by univariate analysis together into the multiple logistic regression model as showing in Table [3](#Tab3){ref-type="table"}, Only occurrence of IPN (*P* = 0.004, OR = 3.012) and MCTSI (*P* = 0.033, OR = 1.183) were proved to be independent risk factors for GIF in SAP. EEN (*P* = 0.016, OR = 0.267) confirmed as a protective factor for GIF in patients with SAP. Unfortunately, blood type B (*P* = 0.048), although just marginal statistical significance was reached, but the 95% confidence interval (0.748--3.562) observed in the multivariate logistic regression are paradoxical. Table [4](#Tab4){ref-type="table"} demonstrates the general characteristics and outcome data of SAP with GIF. Most of GIF (92.3%) occurred beyond the phase of APFC, and diffuse GIF was rarely found in WON. All localized GIF were managed using non-surgical procedures. Forty of 52 fistulas closed spontaneously over time after drainage and the source of infection was controlled. Eight of 40 fistulas closed spontaneously with nothing but conservative supportive management. Seven of 40 patients (17.5%) failed to survive due to MOF or septic shock. For 10 of 12 diffuse GIF, ileostomy or colostomy was performed. Two of them were managed by percutaneous drainage procedure because the patients could not tolerate surgery. Five of fistulas survived and seven (58.3%) died of MOF or other serious complications. The overall mortality was 14 of 52 (26.9%).Table 1Demographic data and clinical characteristics of the patients with SAPCharacteristicGIF (n =52)Non-GIF(n =292)Total(n = 344)P valueAge, years(range)51 (34--77)49(27--70)50(27--77)0.572Gender, M/F32/20160/132192/1520.047Etiology Biliary29156185 Alcohol73542 Hyperlipidemia53742 Idiopathic116475BMI (kg/m2)22.84(16.25--25.72)24.13(16.93--28.32)23.05(16.20--28.42)0.053EEN102042140.001APACHE II score16(11--19)10(8--15)10(8--16)0.035MCTSI8(6--10)6(6--8)6(6--10)0.039CRP level(mg/dl)143.0(85.0--186.0)124.6(50.6--184.3)128.0(64.5--187.0)0.027Albumin10(8--20)14(11--24)13(10--28)0.046B blood type1655710.022IAP(mmHg)10.50(9--12.48)8.50(6.35--11.50)9.20(6.54--11.75)0.093ascites301521820.419thrombosis938470.181IPN431371800.032death1462750.754*M* male, *F* female, *APACHE* Acute Physiology and Chronic Health Evaluation, *BMI* body mass index, *EEN* the early enteral nutrition, *CRP* C-reactive protein, *IAP* intra-abdominal pressure, *MCTSI* modified CT severity index, *IPN* infected pancreatic and extra-pancreatic necrosis Table 2Univariate logistic regression analysis of GIFVariableOR95% CI*P* valueLowerUpperAge1.4060.9721.7320.937Gender1.0310.9481.4310.873Alcohol1.3700.2530.7240.284Hyperlipidemia2.4710.5422.7970.029BMI1.1511.0171.3140.056APACHE II score1.6320.9513.1180.044MCTSI4.2331.0264.9650.025CRP level1.9730.9272.5310.172EEN0.3460.2530.7640.004Albumin2.4270.8622.2530.122B blood type2.9941.1816.1370.036IAP1.0380.9291.2870.087ascites1.2790.7643.2490.126thrombosis1.8780.9123.1040.201IPN3.1741.78311.9020.002*APACHE* Acute Physiology and Chronic Health Evaluation, BMI body mass index, *EEN* the early enteral nutrition, *CRP* C-reactive protein, *IAP* intra-abdominal pressure, *MCTSI* modified CT severity index, *IPN* infected pancreatic and extra-pancreatic necrosis Table 3Independent risk factors in a multivariate logistic regression analysis of GIFVariableOR95% CI*P* valueLowerUpperOccurrence of IPN3.0121.69315.0260.004EEN0.2670.1820.7380.016MCTSI1.1831.0962.5470.037B blood type1.0060.7483.5620.048*IPN* infected pancreatic and extra-pancreatic necrosis, *EEN* the early enteral nutrition, *MCTSI* modified CT severity index Table 4General characteristics data of SAP with GIFGIF stylePhaseManagementDeathAPFCINPWONoperationdrainageSelfhealingLocalization2122603287/40diffusion210010207/12total422261034814/52*APFC* acute pancreatic or peripancreatic fluid collection, *WON* walled-off necrosis, *IPN* infected pancreatic or peripancreatic necrosis

Discussion {#Sec10}
==========

GIF is a well-recognized complication that occurs in the late phase of AP. However, the clinical relevance of GIF in patients with AP has been rarely studied by investigators, and the reported incidence ranges from 3 to 12% in different studies \[[@CR28]--[@CR30]\]. In the present retrospective study, GIF developed in 52 of 344 patients (15.12%), which was relatively higher than previously reported. The higher incidence should be mainly due to screening only SAP patients for enrollment in our study, and in addition, some critical patients admitted to our center who were transferred from other facilities.

We evaluated 15 potential risk factors for GIF in SAP patients and demonstrated the occurrence of IPN resulting from ANC or WON and high MCTSI to be independent risk factors (*P* = 0.004, OR = 3.012; *P* = 0.037, OR = 1.183). EEN acted as a protective factor for GIF with SAP (*P* = 0.0001, OR = 1.006). Unfortunately, our data suggested that blood type B was also correlated with GIF (*P* = 0.048, OR = 1.006), not only less strongly, but the 95% confidence interval (0.748^\_^3.562) was paradoxical based on multivariate logistic regression.

Previous studies have confirmed infection of pancreatic necrosis can be observed in 25^\_^70% of patients with necrotizing disease \[[@CR31]\]. Occurrence of pancreatic and peripancreatic necrosis and formation of WON serve as nidus for bacterial superinfection are prone to develop infections which thought to be involved in the pathogenesis of GIF. The microbial pathogens that cause IPN in necrotizing pancreatitis are predominantly gut-derived \[[@CR32]\]. A transition from a pro-inflammatory to an anti-inflammatory response occurs within the first 1^\_^2 weeks, the patient is at risk for the translocation of intestinal flora as a result of intestinal barrier failure followed by the development of consequent IPN and fluid collections, which is thought to be associated with severe local inflammatory response and may erode the blood vessel directly, stimulate vessel spasm, enhance thrombosis, and reduce capillary perfusion, especially, when secondary infection occurs \[[@CR33]\]. Inflammation or infected necrosis and enzyme-rich fluid can exacerbate the condition of gastrointestinal (GI) tract, which facilitate the formation of oedema, thrombosis, ischemia, necrosis and resulting in formation of fistula eventually \[[@CR11]\]. With respect to the time of occurrence of GIF during the course of SAP, 85% patients had GIF beyond 4^\_^8 weeks \[[@CR34]\], which suggests that the development of GIF is associated with the long-term effects of the pancreatic or peripancreatic inflammation and infection. The finding is in agreement with our results, as patients with IPN had a higher risk of GIF. Hence, due to the anatomical characteristics of GI tract and the nature of pancreatic necrosis, the region of GIF was local or diffuse, but the underlying pathogenesis of both were same. Timely drainage of infected necrotizing collection could significantly decrease the risk of GIF.

For preventing infections in patients with SAP, recent studies have universally supported the optimal strategy of fluid resuscitation, which involves aggressive fluid administration during the first 24h of admission, highlight optimal targeting of individualized fluid requirements, and utilizing lactated Ringer's as the fluid type of preferred choice \[[@CR35]--[@CR37]\]. Additionally, routine antibiotic or probiotic prophylaxis is recommended for patients with SAP. Antibiotic therapy should be initiated while the source of the infection is suspected or investigated \[[@CR38]\].

Reliable evidence from several randomized controlled trials and meta-analyses comparing the outcomes of EN to parenteral nutrition (PN) in patients with AP has clearly shown the superiority of EN in decreasing the infectious complication rate, MOF, mortality, and length of hospitalization \[[@CR39]\]. Our data suggest that EEN, in contrast to the maximum IPN and maximum WON level, acts as a protective factor for GIF secondary to SAP (*P* = 0.016, OR = 0.267). EN starting in the early phase (48^\_^72h after admission) of SAP is superior to later EN (72 h after admission) and PN. Some studies have demonstrated that EEN can timely deliver nutritional support, while it preserves gut mucosal integrity, inhibits bacterial overgrowth and translocation, supports splanchnic metabolism, and mitigates the systemic inflammation and risk of infection \[[@CR40], [@CR41]\]. The results of a well-designed multicentric randomized clinical trial did not show positive effects of EEN (within 24 h after admission) against on-demand nutrition (48 h since admission), with the incidence of IPN as an endpoint. Conversely, feeding within the first 24 h might act as a burden, which might be of no benefit to prevent gut-derived infectious complications. Accordingly, it is not recommended to initiate feeding within first 24 h, rather feeding initiated 48 h after admission is more beneficial \[[@CR42], [@CR43]\]. However, SAP is always accompanied with delayed gastric emptying and intestinal ileus that lead to anorexia, nausea, and vomiting that prevent the patient from tolerating oral fluids and diet. And ventilator support executing sedation in the ICU preclude oral feeding in patients with SAP. So EN need to be supplied via nasogastric (NG), nasoduodenal, or nasojejunal (NJ) feeding. In patients who have gastric outlet obstruction from pancreatic inflammation or fluid collection related duodenal compression, a nasogastrojejunal (NGJ) tubing system, a double lumen tube with proximal gastric decompression, and distal jejunal feeding ports can be used to meet both the purposes without the need for two separate tubes \[[@CR44], [@CR45]\]. In our center, nasoduodenal feeding tubes as the primary method of enteral feeding were placed by endoscopists or radiologists, NJ and NGJ were managed secondarily if necessary, and fluid feeding was initiated after 48^\_^120 h after admission.

It was confirmed in the present study that patients with SAP and high MCTSI scores were at a higher risk for GIF. The MCTSI is one of the most preferred modality for severity assessment of acute pancreatitis by incorporating extra-pancreatic complications. CECT is considered the non-invasive reference standard for diagnosing AP, and is highly accurate in assessing IPN and its complications when performed 72--96 h after symptom onset \[[@CR24], [@CR46]\]. MCTSI is credited with IPN and involvement of pleural effusion, ascites, vascular or gastrointestinal complications, and as expected, has the greatest accuracy for predicting SAP, which correlates more closely with patient outcome in terms of duration of hospital stay and development of organ failure \[[@CR47], [@CR48]\]. Because MCTSI is intrinsically implicated with gastrointestinal complications, which involves the potential opportunity for occurrence of GIF. MCTSI is inevitably as a sensitive risk factor for GIF in patients with SAP.

Previous reports have suggested that blood type B may be a genetic eliciting factor for chronic autoimmune pancreatitis \[[@CR49]\]. Unfortunately, our results revealed a slight correlation between blood type B and the development of GIF in patients with SAP. For blood type B (*P* = 0.048,OR = 1.006), marginal statistical significance was reached, but there was an ambiguity with respect to the paradoxical 95% confidence interval (0.748^\_^3.562) observed in the multivariate logistic regression, which indicated a weaker association of risk factor for GIF or implied a relatively limited sample size in our study. How the intrinsic relationship between these observed factors is confusedly unclear. Even though our data have shown an association between the development of GIF in patients with SAP and blood type B, previous analyses should not be regarded as an outcome of our study, and further investigation is warranted.

The clinical outcomes, as illustrated in Table [4](#Tab4){ref-type="table"} suggest that patients with SAP in combination with diffuse GIF have much longer hospital stays, more severe complications, extremely poor prognosis, and require more invasive treatments than localized counterparts, which might cause none of additional symptoms and are even detected incidentally \[[@CR4], [@CR50]\]. In our study, only 12 of 52 fistulas (23.1%) were shown to be diffuse GIF, and 40 of 52 fistulas (76.9%) were in localized GIF.

It was easy to neglect GIF because its symptom always overlap with clinical manifestations of SAP, and visible air pockets within the necrotic area on the imaging of CECT are frequently confused with infection of necrosis \[[@CR51], [@CR52]\]. Even diffuse GIF might not be observed timely unless persistent deterioration aroused attention. Nevertheless, the morbidity associated with localized GIF is significantly higher than diffuse GIF. Thus, it is not difficult to explain why there is no remarkably discrepancy in mortality (26.92% vs. 21.23%; *P* = 0.754) related to the SAP between patients with and without GIF, as shown in Table [1](#Tab1){ref-type="table"}. This consistency may be mainly attributed to the following: First, the occurrence of severe intestinal edema, ischemia, necrosis and fistula caused by erosion and necrosis of enzyme-rich fluid and infected necrotic tissue is most localized in the retroperitoneal space and diffusion is limited. Therefore, most GIF of upper GI tract can usually close spontaneously with time if the infected source can be well controlled \[[@CR12], [@CR14]\]. Second, GIF can potentially benefit the patient by draining IPN into GI tract, especially when IPN, WON, or pseudocyst communicate with the gut \[[@CR4], [@CR53]\]. Third, advances in technology, a sufficient nutrition supply, effective anti-infective treatment, and timely surgical intervention have also played extremely important roles \[[@CR54]\].

There were two primary advantages in the present study. First, we observed originally that blood type B is an independent risk factor for GIF in patients with SAP, albeit the relatively small sample of the present study might have reduced the statistical power. Second, we attempted to identify specific, routinely tested and reproducible baseline clinical parameters that predict the risk factors which are associated with GIF secondary to SAP. There were also several limitations to our study. First, this was a retrospective study with a relatively limited sample size. The actual incidence of GIF might be lower than our report because some patients transferred to our center were critical and most had been treated in other facilities for a long time. The non-parametric test applied may bring some uncertainty to the conclusions. Second, the guidelines that some experts recommended (the prophylactic administration of antibiotics and some pharmacologic agents are not necessary in all patients with acute pancreatitis) \[[@CR55]--[@CR58]\] were also not implemented in the present study owing to lacking of uniform experimental assessments. Third, as a relative contra-indication of EN, SAP was associated with delayed gastric emptying and intestinal ileus. EEN might be executed unsuccessfully due to subjective bias of the individual administrator. Finally, by introducing the updated classification of SAP, it was inevitable to make selection bias by ruling in or out patients who were over-or-underestimated due to the seemingly homologous definition. Whether or not these aspects could affect the incidence and analysis of GIF in patients with SAP is uncertain.

Conclusion {#Sec11}
==========

We conclude that occurrence of IPN and higher MCTSI are independent significant risk factors for the development of GIF in patients with SAP. EN in 48--72 h after admission is conformed to be an independent significant protective factor of GIF secondary to SAP. Also the patient with blood type B is predisposed to develop GIF in the patient with SAP, perhaps which need more support.

ANC

:   Acute necrotic collection

APFC

:   Acute pancreatic or peripancreatic fluid collection

EEN

:   Early enteral nutrition

GIF

:   Gastrointestinal fistula

IPN

:   Defined when the presence of the ANCs and WONs development of infection

MCTSI

:   Modified CT severity index

SAP

:   Severe acute pancreatitis

WON

:   and walled-off necrosis
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